Repair or Replace: What Are We Learning From Real-World Studies?
Published: 02 December 2022
-
Views:
5277
-
Likes:
7
-
Views:
5277
-
Likes:
7
-
4m 18sPart 1 | Session 1 Why We Need Real-World Data in Valve Treatment?: Anita Asgar Anita W Asgar, Paolo Denti, Marta Sitges, Maurizio Taramasso, Philipp Lurz
-
7m 21sPart 1 | Session 2 Round-up of Real-World Data in Transcatheter Mitral Valve Replacement: Paolo Denti Paolo Denti
-
5m 22sPart 1 | Session 3 Round-up of Real-World Data in Tricuspid Regurgitation: Philipp Lurz Philipp Lurz
-
7m 44sPart 1 | Session 4 Patient Selection in Mitral Regurgitation: Repair or Replace?: Maurizio Taramasso Maurizio Taramasso
Overview
What are real-world studies telling us about selecting between repair or replace strategies for leaky valves? In this series of videos, we bring you up to date with how the dynamic is changing in favour of transcatheter approaches for a great number of patients, and provide some practical guidance for patient selection in both tricuspid and mitral regurgitation. We also explore how a rapidly accumulating body of real-world evidence is starting to shed light on new patient groups that stand to benefit from transcatheter strategies, and seek expert views from both a surgical and interventional perspective on the future success of these treatments.
Filmed following data released at PCR London Valves 2022, our faculty examine some of the latest real-world data on mitral and tricuspid regurgitation and put this data into context for practitioners.
Learning Objectives
- Describe the value of real-world data in the treatment of mitral and tricuspid regurgitation
- Review how patient selection for repair or replacement strategies may change in the near future
- Identify patient groups in whom transcatheter repair and replacement strategies may be preferable over surgical approaches
- Understand the value of surgical teams for transcatheter valve interventions
- Recall the latest real-world evidence on transcatheter repair and replacement treatments for tricuspid and mitral regurgitation
Target Audience
- Interventional Cardiologists
- Cardiac Surgeons
- Heart Failure Specialists
- General Cardiologists
More from this programme
Part 1
Repair or Replace: What Are We Learning From Real-World Studies?
Faculty Biographies
Marta Sitges
Director, Cardiovascular Institute
Prof Marta Sitges is a senior consultant non-invasive cardiologist at the Cardiovascular Institute in Hospital Clinic and Professor of Medicine at the University of Barcelona. She has also been the Director of the Cardiovascular Institute since October 2015.
Her main clinical practice is related to clinical and interventional echocardiography, sports cardiology and heart valve disease. She has an extensive publication track in these fields with participation in leading National and International meetings, she has received more than 60 peer reviewed grants and directed multiple MD and PhD thesis.